Skip to content

Effects of Ciprofol and Propofol on Blood Pressure in Elderly Patients Undergoing Neurointerventional Surgery: A Single-Center Randomized Controlled Trial

Effects of Ciprofol and Propofol on Blood Pressure in Elderly Patients Undergoing Neurointerventional Surgery: A Single-Center Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121369
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular stenosis or unruptured high-risk intracranial aneurysm

Interventions

Control group:Anesthesia was induced with 0.3 µg/kg sufentanil, 1.5–2 mg/kg propofol, and 0.6 mg/kg rocuronium. Anesthesia was maintained with continuous infusions of remifentanil and propofol to main
Experimental Group:Anesthesia was induced with 0.3 µg/kg sufentanil, 0.3–0.4 mg/kg ciprofol, and 0.6 mg/kg rocuronium. Anesthesia was maintained with continuous infusions of remifentanil and ciprofol

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years old; 2. Diagnosed with cerebrovascular stenosis or unruptured high-risk intracranial aneurysm by DSA or CTA; 3. Elective cerebrovascular stent placement or intracranial aneurysm embolization; 4. Signed informed consent form

Exclusion criteria

Exclusion criteria: 1. Emergency neurointerventional surgery; 2. Patient has a history of severe cardiovascular and pulmonary disease; 3. Severe liver and kidney dysfunction; 4. Anticipated difficult airway or difficulty with postoperative extubation; 5. Comorbid morbid obesity, defined as BMI >= 35 kg/m^2; 6. Allergy to contrast agents or general anesthetics; 7. Difficulty in preoperative communication and interaction.

Design outcomes

Primary

MeasureTime frame
The area under the curve of MAP relative to baseline MAP during anesthesia induction and maintenance.;

Secondary

MeasureTime frame
Time-weighted average of AUC-bMAP (TWA-bMAP);coefficient of variation (CV) of MAP;average real variability (ARV) of MAP;incidence of hypotension;lowest MAP;cumulative dose of vasopressors;postoperative recovery parameters (extubation time, awakening time, length of hospital stay);

Countries

China

Contacts

Public ContactHan Ruquan

Beijing Tiantan Hospital, Capital Medical University

hanrq666@aliyun.com+86 10 5997 6656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026